Bodal Chemicals Limited (BOM:524370)
India · Delayed Price · Currency is INR 44.56
-0.31 (-0.69%)
At close: Mar 5, 2026
Bodal Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 18,716 | 17,449 | 13,946 | 15,743 | 20,553 | 12,264 |
| 18,716 | 17,449 | 13,946 | 15,743 | 20,553 | 12,264 | |
Revenue Growth (YoY) | 10.90% | 25.12% | -11.41% | -23.40% | 67.58% | -10.79% |
Cost of Revenue | 10,506 | 9,321 | 7,333 | 9,254 | 11,924 | 8,251 |
Gross Profit | 8,210 | 8,129 | 6,613 | 6,488 | 8,628 | 4,013 |
Selling, General & Admin | 1,286 | 1,166 | 1,039 | 962.12 | 1,120 | 789.98 |
Other Operating Expenses | 5,430 | 5,229 | 4,465 | 4,145 | 5,246 | 2,140 |
Operating Expenses | 7,411 | 7,080 | 6,109 | 5,638 | 6,832 | 3,236 |
Operating Income | 799.32 | 1,049 | 504.14 | 850.22 | 1,796 | 776.92 |
Interest Expense | -802.34 | -798.27 | -506.81 | -392.1 | -274.75 | -143.3 |
Interest & Investment Income | 70.69 | 70.69 | 104.13 | 78.86 | 120.06 | 77.76 |
Currency Exchange Gain (Loss) | -24.26 | -24.26 | 50.08 | -47.74 | -63.7 | 2.27 |
Other Non Operating Income (Expenses) | 317.57 | -13.62 | -30.03 | 1.78 | -16.7 | -17.86 |
EBT Excluding Unusual Items | 360.98 | 283.24 | 121.51 | 491.02 | 1,561 | 695.79 |
Gain (Loss) on Sale of Investments | 3.36 | 3.36 | -2.12 | 3.61 | 40.52 | 32.46 |
Gain (Loss) on Sale of Assets | 1.69 | 1.69 | 87.94 | 13.59 | 7.07 | -1.16 |
Other Unusual Items | -66.99 | -95.2 | -160.06 | 0.14 | -187.88 | -173.25 |
Pretax Income | 299.04 | 193.09 | 47.27 | 508.36 | 1,420 | 553.84 |
Income Tax Expense | -3.68 | 8.07 | -17.42 | 128.03 | 433.82 | 156.17 |
Earnings From Continuing Operations | 302.72 | 185.02 | 64.69 | 380.33 | 986.63 | 397.67 |
Minority Interest in Earnings | - | - | - | - | 55.65 | 22.15 |
Net Income | 302.72 | 185.02 | 64.69 | 380.33 | 1,042 | 419.82 |
Net Income to Common | 302.72 | 185.02 | 64.69 | 380.33 | 1,042 | 419.82 |
Net Income Growth | 401.27% | 186.01% | -82.99% | -63.51% | 148.27% | -51.84% |
Shares Outstanding (Basic) | 127 | 126 | 126 | 126 | 125 | 122 |
Shares Outstanding (Diluted) | 127 | 126 | 126 | 126 | 125 | 123 |
Shares Change (YoY) | 1.76% | 0.08% | 0.19% | 0.10% | 2.34% | 0.29% |
EPS (Basic) | 2.39 | 1.47 | 0.51 | 3.03 | 8.31 | 3.43 |
EPS (Diluted) | 2.39 | 1.47 | 0.51 | 3.03 | 8.30 | 3.43 |
EPS Growth | 397.06% | 188.18% | -83.17% | -63.50% | 142.28% | -51.95% |
Free Cash Flow | - | 673.32 | -407.19 | -478.63 | -1,726 | -1,911 |
Free Cash Flow Per Share | - | 5.35 | -3.24 | -3.81 | -13.76 | -15.60 |
Dividend Per Share | - | - | - | 0.100 | 0.800 | 0.800 |
Dividend Growth | - | - | - | -87.50% | - | - |
Gross Margin | 43.87% | 46.58% | 47.42% | 41.22% | 41.98% | 32.72% |
Operating Margin | 4.27% | 6.01% | 3.62% | 5.40% | 8.74% | 6.33% |
Profit Margin | 1.62% | 1.06% | 0.46% | 2.42% | 5.07% | 3.42% |
Free Cash Flow Margin | - | 3.86% | -2.92% | -3.04% | -8.40% | -15.58% |
EBITDA | 1,530 | 1,720 | 1,098 | 1,374 | 2,259 | 1,078 |
EBITDA Margin | 8.17% | 9.86% | 7.87% | 8.73% | 10.99% | 8.79% |
D&A For EBITDA | 730.28 | 671.74 | 593.69 | 523.85 | 463.61 | 301.33 |
EBIT | 799.32 | 1,049 | 504.14 | 850.22 | 1,796 | 776.92 |
EBIT Margin | 4.27% | 6.01% | 3.62% | 5.40% | 8.74% | 6.33% |
Effective Tax Rate | - | 4.18% | - | 25.19% | 30.54% | 28.20% |
Revenue as Reported | 19,165 | 17,567 | 14,194 | 15,859 | 20,724 | 12,424 |
Advertising Expenses | - | 17.61 | 11.23 | 14.06 | 15.77 | 12.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.